Extracellular water expansion: Part of the malnutrition-inflammation-atherosclerosis syndrome?

Peritoneal Dialysis International

Volumn 26, Issue 5, 2006, Pages 566-570

  Woodrow, Graham ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ATHEROSCLEROSIS; BODY FAT; CHRONIC KIDNEY DISEASE; EXTRACELLULAR FLUID; FLUID BALANCE; FLUID INTAKE; HUMAN; HYPOTHESIS; INFLAMMATION; INTRACELLULAR FLUID; KIDNEY FAILURE; MALNUTRITION; MORTALITY; NOTE; PATHOPHYSIOLOGY; PATIENT MONITORING; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; SODIUM INTAKE; SYNDROME; TOTAL BODY WATER;

EID: 33750557678     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600508     Document Type: Note

References (41)

1. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999; 55:1899-911.
2. Pecoits-Filho R, Stenvinkel P, Wang AYM, Heimbürger O, Lindholm B. Chronic inflammation in peritoneal dialysis: the search for the holy grail? Perit Dial Int 2004; 24: 327-39.
3. Noh H, Lee SW, Kang SW, Shin SK, Choi KH, Lee HY, et al. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18:387-94.
4. Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int 2002; 62: 1417-22.
5. Young GA, Kopple JD, Lindholm B, Vonesh EF, DeVecchi A, Scalamogna A, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991; 17:462-71.
6. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15:953-60.
7. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3):S112-19.
8. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321:199-204.
9. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-38.
10. Haubitz M, Brunkhorst R. C-reactive protein and chronic Chlamydia pneumoniae infection - long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 2001; 16:809-15.
11. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
12. Konings CJAM, Kooman JP, Schonk M, Dammers R, Cheriex E, Meulmans APP, et al. Fluid status, blood pressure and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-87.
13. Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 2001; 16:1459-64.
14. Koc M, Toprak A, Tezcan H, Bihorac A, Akoglu E, Ozener IC. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant 2002; 17:1661-6.
15. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Ertürk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
16. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14:2948-57.
17. Günal AI, Duman S, Özkahaya M, Töz H, Asci G, Akçiçek F, et al. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 588-93.
18. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson A-C, et al. Icodextrin improves fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.
19. Konings CJAM, Kooman JP, Schonck M, Gladziwa U, Wirtz J, Van Den Wall Bake AW, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63:1556-63.
20. Asci G, Özkahaya M, Duman S, Toz H, Erten S, Ok E. Volume control associated with better cardiac function in long-term peritoneal dialysis patients. Perit Dial Int 2006; 26:85-8.
21. Ávila-Díaz M, Ventura MJ, Valle D, Vicenté-Martínez M, García-González Z, Cisneros A, et al. Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int 2006; 26:574-80.
22. Vicenté-Martínez M, Martínez-Ramírez L, Munoz R, Avila M, Ventura MJ, Rodríguez E, et al. Inflammation in patients on peritoneal dialysis is associated with increased extracellular fluid volume. Arch Med Res 2004; 35:220-4.
23. Konings CJAM, Kooman JP, Schonk M, Struijk DG, Gladziwa U, Hoorntje SJ, et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 2003; 18:797-803.
24. Cheng LT, Tang W, Wang T. Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis 2005; 45:891-902.
25. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349: 1050-3.
26. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992; 85:1364-73.
27. Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart 2004; 90: 464-70.
28. Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996; 77:723-7.
29. Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJS. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997; 79: 1426-30.
30. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353:1838-42.
31. Genth-Zotz S, von Haehling S, Bolger AP, Kalra PR, Wensel R, Coats AJS, et al. Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. Am J Cardiol 2002; 90:1226-30.
32. Pecoits-Filho R, Araújo MRT, Lindholm B, Stenvinkel P, Abensur H, Romäo JE, et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17: 1480-6.
33. Rodrigues AS, Almeida M, Fonseca I, Martins M, Carvalho MJ, Silva F, et al. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with inflammation. Nephrol Dial Transplant 2006; 21:763-9.
34. Chung SH, Heimbürger O, Stenvinkel P, Wang T, Lindholm B. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int 2003; 23:174-83.
35. Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003; 41: 1212-18.
36. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-57.
37. Jones CH, Wells L, Stoves JJ, Farquhar F, Woodrow G. Can reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 2002; 39:872-5.
38. Woodrow G, Oldroyd B, Wright A, Coward A, Turney JH, Brownjohn AM, et al. Abnormalities of body composition in peritoneal dialysis patients. Perit Dial Int 2004; 24: 169-75.
39. Woodrow G, Oldroyd B, Wright A, Coward A, Truscott JG. Effect of normalization of ECW volume as a marker of hydration in peritoneal dialysis patients and controls. Perit Dial Int 2005; 25(Suppl 3):S49-51.
40. Waki M, Kral JG, Mazariegos M, Wang J, Pierson RN, Heymsfield SB. Relative expansion of extracellular fluid in obese vs. nonobese women. Am J Physiol 1991; 261 (2 Pt 1):E199-E203.
41. Heimbürger O, Stenvinkel P. Adipokines in chronic kidney disease - fat tissue gives nephrologists a message. Perit Dial Int 2005; 25:340-2.